BARCROFT MEDICAL CENTRE
THE CENTRE, AMESBURY, SALISBURY
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 25 | 27 | 92.6% | |
| HF 4 | 2011 | 27 | 30 | 90.0% | |
| HF 4 | 2012 | 24 | 25 | 96.0% | |
| HF 4 | 2013 | 19 | 22 | 86.4% | |
| HF004 | 2014 | 12 | 12 | 100.0% | |
| HF004 | 2015 | 9 | 9 | 100.0% | |
| HF004 | 2016 | 11 | 13 | 84.6% | |
| HF004 | 2017 | 17 | 17 | 100.0% | |
| HF004 | 2018 | 19 | 19 | 100.0% | |
| HF004 | 2019 | 28 | 34 | 82.4% | |
| HF004 | 2020 | 29 | 35 | 82.9% | |
| HF006 | 2021 | 54 | 54 | 100.0% | |
| HF006 | 2022 | 53 | 57 | 93.0% | |
| HF006 | 2023 | 62 | 64 | 96.9% |
